Underdosing of appetite depressants, subsequent encounter

This code signifies a patient's insufficient intake of a prescribed appetite suppressant medication, leading to an inadequate therapeutic effect. This underdosing is being addressed during a follow-up visit after the initial encounter for the underdosing event.

Apply this code when a patient presents for a subsequent visit related to not taking enough of their appetite suppressant, such as phentermine or liraglutide, as prescribed. This could involve follow-up appointments to adjust dosage, review medication adherence, or manage ongoing weight-related issues due to the underdosing.

• Ensure documentation clearly indicates "underdosing" and specifies the medication as an "appetite suppressant."
• Confirm the encounter is not the initial visit for the underdosing; look for terms like "follow-up," "subsequent visit," or "ongoing management."
• Always code with an additional diagnosis code for the condition being treated by the appetite suppressant (e.g., obesity, morbid obesity).